Description
Monash Antibody Technologies Facility (MATF) is a global source of costeffective high quality, high affinity custom monoclonal antibodies. Our team of highly skilled scientists employ well-established standard operating procedures, along with the latest automated screening techniques, to deliver monoclonal antibodies in 20 weeks. Project deliverables are flexible and designed around the specific needs of our clients.
Contact information
| Phone | +61 (3) 9905 8906 |
|---|---|
| Emails | info.matf@monash.edu |
| Links | Unspecified, Unspecified, Website |
Terms of loan/booking
Available for loan - internal only
Related content
Projects
Immunobiology and Immunotherapy of Cancer
Project: Research
Hyperleptinemia in obesity is a cause of central insulin resistance
Project: Research
Design and engineering of adnectins for diagnosis and therapy
Project: Research
Proof-of-concept studies for a novel anti-thrombotic agent
Project: Research
The Meydan Family Foundation Diabetes Complications Research Hub
Project: Research
Smart Targeted Nanoparticles for Diagnosis and Therapy
Project: Research
The role of Il21 in B-cell activation
Project: Research
IL21, B-cell Proliferation and the Mechanism of Memory Formation
Project: Research
Activation and inhibition of the Plasminogen/Plasmin system
Project: Research
Does the amount of PAR4 on the platelet surface regulate thrombosis?
Project: Research
Targeting cytokine signalling in systemic lupus erythematosus
Project: Research
Pathology Lab on-a-chip
Project: Research
Research Output
An investigation into the Omp85 protein BamK in hypervirulent Klebsiella pneumoniae, and its role in outer membrane biogenesis
Research output: Contribution to journal › Article › Research › peer-review
New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells
Research output: Contribution to journal › Article › Research › peer-review